ASND — ASCENDIS PHARMA A/S

Ownership history in CSS LLC/IL · 7 quarters on record

This page tracks every 13F SEC filing in which CSS LLC/IL reported a position in ASCENDIS PHARMA A/S (ASND). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.03% (2021 Q3)

Avg. % of fund

0.02%

First filed

2021 Q3

Last filed

2025 Q4

Quarters held

7

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q4	UNCHANGED	2,000	—	0%	0.02%	$426K	$213.24
2025 Q3	UNCHANGED	2,000	—	0%	0.02%	$398K	$198.81
2025 Q3	ADDED	2,000	+1,500	+300.0%	0.02%	$398K	$198.81
2022 Q1	REDUCED	500	-5,600	-91.8%	0.00%	$59K	$117.36

% of Fund (quarterly) ASND price (monthly, adj. close)

Other funds also holding ASND

As of 2025 Q4 — sorted by position size

Q Global Advisors, LLC 3Y 7Y 39.86% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 22.46% Avoro Capital Advisors LLC 3Y 7Y 10.71% Resolute Capital Asset Partners LLC 3Y 9.13% Tri Locum Partners LP 3Y 7.34% WESTFIELD CAPITAL MANAGEMENT CO LP 3Y 7Y 4.61% Catalio Capital Management, LP 4.49% Spyglass Capital Management LLC 3Y 7Y 4.43% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.11% PFM Health Sciences, LP 3Y 7Y 3.78%

← Back to CSS LLC/IL Holdings